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Introduction
Hemodynamic monitoring plays an important role in the 
management of today’s acutely ill patient. Essentially, 
hemodynamic monitoring can be helpful in two key 
settings. Th e ﬁ rst is when a problem has been recognized; 
here, monitoring can help to identify underlying patho-
physiological processes so that appropriate forms of 
therapy can be selected. A typical scenario is the patient 
in shock for whom options are to give more ﬂ uids or to 
give a vasopressor or an inotropic agent, depending on 
the hemodynamic evaluation. Th e second setting is more 
preventative, with monitoring allowing preemptive 
actions to be performed before a signiﬁ cant problem 
arises. A typical scenario here is the perioperative patient 
in whom monitoring can be used to detect hypovolemia 
or low oxygen delivery (DO2) early, enabling timely 
corrective therapy to be initiated.
Although microcirculatory changes are believed to play 
a major role in the development of organ dysfunction and 
multiple organ failure and there is increasing interest in 
new techniques to monitor the microcirculation, these 
are not yet available for clinical practice, and hemo-
dynamic monitoring, therefore, still focuses on the macro-
circulation. Current hemodynamic monitoring there fore 
includes measurement of heart rate, arterial pressure, 
cardiac ﬁ lling pressures or volumes, cardiac output, and 
mixed venous oxygen saturation (SvO2). Although not 
perfect, the pulmonary artery catheter (PAC) has long 
been considered the optimal form of hemodynamic 
monitoring, allowing for the almost continuous, 
simultaneous recording of pulmonary artery and cardiac 
ﬁ lling pressures, cardiac output and SvO2. However, 
although the incidence of complications with the PAC is 
relatively low, the technique is still quite invasive and 
there is no clear evidence for improved outcomes asso-
ciated with its insertion and use to guide therapy [1]. As a 
result, interest in alternative monitoring systems has 
surged in recent years.
Th ere are now many diﬀ erent monitoring systems 
available, and physicians may feel somewhat confused by 
the multiple possibilities. Th ese systems can be easily 
listed in order of degree of invasiveness, from the highly 
invasive PAC to the completely non-invasive bioimpedance/
bioreactance technique and transthoracic echo-Doppler. 
Classifying them according to how accurate (closeness of 
measured values to the ‘true’ value, expressed as the bias) 
or precise (variability of values due to random errors of 
measurement) [2] they are is more diﬃ  cult, in part 
because of the lack of a perfect ‘gold’ standard for com-
parison. Most devices have been evaluated by comparing 
their results with those obtained by intermittent thermo-
dilution from the PAC as the reference, although this 
technique has its own limitations and may not represent 
the best choice of comparator [2].
Our purpose in this consensus article is not to review 
the technology or modus operandi of the various systems 
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in any detail, not to provide readers with a shopping list, 
nor to identify one system that would be suitable in all 
patients; rather, we will brieﬂ y review the advantages and 
limitations of each system, and propose ten key principles 
to guide choice of monitoring system(s) in today’s acutely 
ill patients.
Available systems for monitoring cardiac output
Examples of the main systems that are available for 
estimating cardiac output are listed in Table 1.
Thermodilution (pulmonary artery catheter)
Th e intermittent thermodilution technique, in which 
boluses of ice-cold ﬂ uid are injected into the right atrium 
via a PAC and the change in temperature detected in the 
blood of the pulmonary artery used to calculate cardiac 
output, is still widely considered as the standard method 
of reference. Adaptation of the PAC to incorporate a 
thermal ﬁ lament (Vigilance™, Edwards Life Sciences, 
Irvine, CA, USA) or thermal coil (OptiQ™, ICU Medical, 
San Clemente, CA, USA) that warms blood in the 
superior vena cava and measures changes in blood 
temperature at the PAC tip using a thermistor, provides a 
continuous measure of the trend in cardiac output, with 
the displayed values representing an average of the values 
over the previous 10 minutes. Th e averaged values have 
the advantage of eliminating variability in the presence of 
arrhythmias, but the disadvantage of not being real-time 
values, thus limiting the usefulness of this approach for 
assessing rapid hemodynamic changes in unstable 
patients.
Th e PAC has a key advantage over many other systems 
in that it provides simultaneous measurements of other 
hemodynamic parameters in addition to cardiac output, 
including pulmonary artery pressures, right-sided and 
left-sided ﬁ lling pressures, and SvO2.
Transpulmonary or ultrasound indicator dilution
Th e PiCCO® (Pulsion Medical Systems, Munich, Germany), 
LiDCO™ (LiDCO Ltd, London, UK), VolumeView™ 
(Edwards Life Sciences), and COstatus® (Transonic Systems 
Inc., Ithaca, NY, USA) systems allow cardiac output to be 
investigated less invasively, using a central venous (to 
allow calibration) and an arterial catheter, rather than 
needing to introduce a catheter into the pulmonary 
artery. Th e PiCCO® and recently launched VolumeView™ 
systems require a femoral artery catheter. Th ese devices 
use the same basic principles of dilution to estimate the 
cardiac output as with PAC thermodilution. PiCCO® and 
VolumeView™ use injections of ice cold intravenous ﬂ uid 
Table 1. Examples of available methods to measure cardiac output
Method System Limitations
Thermodilution PAC Invasiveness - training required
  
Transpulmonary  PiCCO® Decreased accuracy?
indicator dilution  Need for dedicated arterial catheter
 LiDCO™ Decreased accuracy?
  Need for lithium injection
  Interference by non-depolarizing muscle relaxants; inaccurate in case of 
  hyponatremia
 COstatus® Decreased accuracy?
 VolumeView™ Decreased accuracy?
  Need for dedicated arterial catheter
  
Arterial-pressure  PiCCO®, LiDCO™, Vigileo™,  Decreased accuracy, need for optimal arterial pressure tracing
waveform-derived MostCare™ 
  
Esophageal Doppler CardioQ™, WAKIe TO Training required, intermittent measurement
  
Suprasternal Doppler USCOM® Diffi  cult in some patients
  
Echocardiography Vivid™, Sonosite MicroMaxx®,  Training required, intermittent measurement
 Philips CX50™, and so on
  
Partial CO2 rebreathing NiCO® Less reliable in respiratory failure
  
Bioimpedance Lifegard®, TEBCO®, Hotman®,  Less reliable in critically ill patients, not applicable in cardiothoracic surgery
 BioZ®, and so on 
  
Bioreactance NICOM® Validated in only one study in critically ill patients
PAC, pulmonary artery catheter.
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as the indicator, measuring change in temperature down-
stream to calculate cardiac output, whereas LiDCO™ uses 
minute amounts of lithium chloride as the indicator and 
measures levels using a lithium-selective electrode. 
COstatus® calculates cardiac output by using ultrasound 
technology to measure changes in blood ultrasound 
velocity and blood ﬂ ow following an injection of warm 
saline solution.
Cardiac output values measured using transpulmonary 
or ultrasound indicator dilution techniques correlate well 
with those measured using PAC thermodilution [3-6] 
and may show less respiratory phase-dependent variation 
[4]. Th e PiCCO® and the VolumeView™ systems provide 
variables in addition to cardiac output, such as global 
end-diastolic volume and measurements of extravascular 
lung water. Th e COstatus® system also provides some 
derived variables, including total end diastolic volume 
index.
Arterial pressure trace-derived estimation of cardiac 
output
In addition to the intermittent indicator dilution cardiac 
output measurements discussed above, the PiCCO® and 
LiDCO™ systems can also estimate cardiac output on a 
con tinuous basis from the arterial pressure waveform 
with (PiCCO2® and LiDCOplus™) or without (LidCOrapid™) 
the need for recalibration when changes in vascular com-
pliance may have occurred. Th e PiCCO® system uses a 
pulse contour analysis and the LiDCO™ system a pulse 
power analysis. In addition to these, Vigileo™ (Edwards 
Life Sciences) and MostCare™ (Vytech, Padova, Italy, 
using the Pressure Recording Analytical Method (PRAM)) 
systems have been developed for arterial waveform 
analysis without external calibration. Each of these 
systems contains a proprietary algorithm for converting a 
pressure-based signal into a ﬂ ow measurement. Th e 
speciﬁ c algorithms have individual characteristics and 
make diﬀ erent assumptions - for example, related to 
arterial compliance (Vigileo™) or pressure (MostCare™) - 
which can make them more or less accurate depending 
on the clinical circumstances. Th e level of accuracy and 
precision of each device needs to be understood as the 
data cannot be superimposed from one system to 
another. Th e advantages of these arterial pressure-based 
cardiac output monitoring systems over PAC-derived 
measurements is primarily their less invasive nature.
Th e major weakness of all these devices is the drift in 
values whenever there is a major change in vascular 
compliance, as, for example, in vascular leak syndrome 
with increased vessel wall edema leading to decreased 
arterial compliance. Aortic valve regurgitation may 
further decrease the accuracy of these techniques. Over- 
or under-damped arterial pressure waveforms will also 
decrease the precision of these monitors.
Echocardiography and echo-Doppler
Echocardiography allows measurement of cardiac output 
using standard two-dimensional imaging or, more com-
monly, Doppler-based methods. Th e main interest in 
echocardiography in general is that it can be used not 
only for measurement of cardiac output but also for the 
additional assessment of cardiac function. Echo cardio-
graphy is particularly useful as a diagnostic tool because 
it allows the visualization of cardiac chambers, valves and 
pericardium. Small ventricles (‘kissing ventricles’) may 
incite ﬂ uid administration whereas a poorly contractile 
myocardium may suggest that a dobutamine infusion is a 
better choice. Right ventricular dilatation may orient 
towards the diagnosis of massive pulmonary embolism or 
myocardial infarction whereas the presence of pericardial 
ﬂ uid may suggest a diagnosis of pericardial tamponade. 
Severe valvulopathy can also be recognized promptly. 
However, echocardiography instruments and expertise 
may not be readily available everywhere; in some 
institutions, this is still the domain of the cardiologists 
and they need to be called to do the procedure.
If an ultrasound beam is directed along the aorta using a 
probe, part of the ultrasound signal will be reﬂ ected back 
by the moving red blood cells at a diﬀ erent frequency. Th e 
resultant Doppler shift in the frequency can be used to 
calculate the ﬂ ow velocity and volume and hence cardiac 
output. Echo-Doppler evaluation can provide reasonable 
estimates of cardiac output, but again is operator-
dependent and continuous measurement of cardiac 
output using this technique is not possible. Echo-Doppler 
evalu ation may be applied either trans thoraci cally or 
trans esophageally. However, transthoracic tech niques do 
not always yield good images and trans esophageal 
techniques are more invasive such that some sedation, 
and often endotracheal intubation, is required in order to 
obtain reliable measurements. Moreover, the esophageal 
probe is uncomfortable in non-intubated patients, 
although may be better tolerated if inserted nasally, and 
should be used cautiously in patients with esophageal 
lesions. Th e signal produces diﬀ erent wave forms that can 
be used to distinguish to some extent changes in preload, 
afterload and left ventricular contrac tility. Doppler ﬂ ow 
studies focusing on the descending thoracic aorta may not 
provide a reliable measurement of the total cardiac output 
(for example, with epidural use), and are invalid in the 
presence of intra-aortic balloon pumping. Echo-Doppler 
cardiac output estimates vary considerably for several 
reasons, including diﬃ  culty in assessment of the velocity 
time integral, calculation error due to the angle of 
insonation, and problems with correct measurement of 
the cross-sectional area. Some training is required when 
using these techniques. Esophageal-Doppler techniques 
have been shown to be useful for optimizing ﬂ uid 
adminis tration in high risk surgical patients [7,8].
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Simpliﬁ ed transesophageal Doppler techniques can be 
convenient as the probe is smaller than for standard 
esophageal echocardiography techniques. Simpliﬁ ed trans-
thoracic Doppler systems allow estimation of aortic blood 
ﬂ ow and may be even less invasive; however, although these 
techniques can be simple to perform in healthy volun-
teers, access to good images may be more diﬃ  cult in 
critically ill patients. Moreover, there is a fairly prolonged 
learning curve for correct use of this system [9]. Th ese 
methods need further validation in critically ill patients.
CO2 rebreathing
CO2 rebreathing systems, based on the Fick principle, use 
a CO2 sensor, a disposable airﬂ ow sensor and a disposable 
rebreathing loop. CO2 production is calculated from 
minute ventilation and its CO2 content, and the arterial 
CO2 content is estimated from end-tidal CO2. Partial re-
breathing reduces CO2 elimination and increases the 
end-tidal CO2. By combining measurements taken during 
and without rebreathing, venous CO2 content can be 
eliminated from the Fick equation. However, intra-
pulmonary shunting of blood and rapid hemodynamic 
changes aﬀ ect the accuracy of the measurement, so that 
this technique is not considered to be reliable in acutely 
ill patients.
Bioimpedance and bioreactance
Bioimpedance is based on the fact that the conductivity 
of a high-frequency, low-magnitude alternating current 
passed across the thorax changes as blood ﬂ ow varies 
with each cardiac cycle. Th ese changes can be measured 
using electrodes placed on a patient’s chest and used to 
generate a waveform from which cardiac output can be 
calculated. Bioreactance has developed out of bio-
impedance and measures changes in the frequency of the 
electrical currents traversing the chest, rather than 
changes in impedance, potentially making it less sensitive 
to noise. Th ese techniques are non-invasive and can be 
applied quickly. Th ey have been used for physiological 
studies in healthy individuals and may be useful in 
perioperative applications [10], but are less reliable in 
critically ill patients [11]. Electrical interference may also 
occur in the ICU environment.
Key principles of hemodynamic monitoring
Having brieﬂ y discussed some of the advantages and 
limitations of the available systems, we now consider 
some key principles than can help when considering 
which hemodynamic monitoring system to use.
Principle 1: no hemodynamic monitoring technique can 
improve outcome by itself
Hemodynamic monitoring can only improve outcomes if 
three conditions are met: the data obtained from the 
monitoring device must be suﬃ  ciently accurate to be able 
to inﬂ uence therapeutic decision making; the data 
obtained from the monitoring system must be relevant to 
the patient being monitored; and changes in management 
made as a result of the data obtained need to be able to 
improve outcomes. If the data are interpreted or applied 
incorrectly, or the therapies themselves are ineﬀ ective or 
harmful, the resultant change in management will not 
improve patient status and may be deleterious.
If these three conditions are not met, monitoring is 
unlikely to be associated with improved outcomes, and 
this may account for the lack of evidence of improved 
outcomes in acutely ill patients with use of any 
monitoring device, not only the PAC [12].
Principle 2: monitoring requirements may vary over time 
and can depend on local equipment availability and 
training
Th e optimal monitoring system will depend on the 
individual patient, the problem already present or 
potentially arising for which the monitoring is required, 
and the devices and expertise available at the institution 
in question.
For initial evaluation of the critically ill patient, an 
invasive approach is still often needed, which includes 
insertion of an arterial catheter and a central venous 
catheter; this is because of the need for secure 
intravenous and arterial access in such patients and the 
presumed increased accuracy of measurements based on 
direct pressure monitoring. Th e data provided can 
already guide initial treatment. Analysis of the arterial 
pressure trace can identify ﬂ uid responsiveness in 
mechanically ventilated patients, although there are some 
limitations to this technique, including adaptation to the 
respirator (often with high doses of sedative agents and 
even paralysis), need for absence of arrhythmias, and use 
of relatively large tidal volumes. Response to passive leg 
raising can be used if beat-by-beat measurements of 
stroke volume are monitored. Once stabilized, less 
invasive monitoring techniques should be employed. 
Importantly, monitoring systems are not necessarily 
mutually exclusive and can sometimes be used to 
complement each other. For example, echocardiography 
can provide additional information in the early assess-
ment of critically ill patients (Figure 1).
Th ere is still a place for the PAC (Swan-Ganz), which 
has the advantage of allowing measurement of cardiac 
ﬁ lling pressures and pulmonary artery pressures, cardiac 
output and SvO2 (and now also extravascular lung water). 
However, although in the past a PAC was inserted early 
in all critically ill patients, today its insertion is no longer 
necessary during initial resuscitation, but should rather 
be reserved for complex cases, for example, patients with 
right ventricular dysfunction, diﬃ  cult assessment of 
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optimal ﬂ uid management, or speciﬁ c cases of cardiac 
failure.
Principle 3: there are no optimal hemodynamic values that 
are applicable to all patients
Although it may be appealing to have some simple 
targets, such as keeping the mean arterial pressure above 
65  mmHg, the central venous pressure (CVP) above 
8 mmHg, or DO2 above 600 mL/minute/M², such targets 
are overly simplistic and may even be potentially 
dangerous. For example, the acceptable minimal arterial 
pressure may be very diﬀ erent in a young individual 
without co-morbidity compared to an elderly athero-
sclerotic, previously hypertensive patient. Likewise, the 
CVP may remain low in adequately resuscitated patients 
or may be high at baseline in patients with pulmonary 
hypertension due to underlying chronic lung disease. 
Similarly, it is diﬃ  cult to deﬁ ne an optimal level of 
cardiac output as cardiac output is an adaptative para-
meter for which there is no single ‘normal’ value, but only 
normal ranges. Since the purpose of the cardiovascular 
system is to match blood ﬂ ow to metabolic demand, and 
this demand may vary widely even over short time 
intervals, targeting a speciﬁ c cardiac output or even 
sustaining a threshold value may be inappropriate. For 
example, keeping a cardiac output above 5 or 6 liters per 
minute in an adult would be like driving constantly at 
80 km/h, whether in a small town or on the freeway. In 
the critically ill, cardiac output increases in sepsis, as in 
anemia, but may be reduced with sedation or anesthesia. 
Multiple factors therefore need to be considered when 
determining whether cardiac output is optimal for a 
particular patient, including the degree of tissue 
perfusion as estimated from a careful clinical examination 
and blood lactate levels (Figure 2). Alarms should thus be 
individualized for each patient and reevaluated regularly.
Principle 4: we need to combine and integrate variables
Any variable on its own provides relatively little infor ma-
tion - it is just one piece of a large puzzle. We need rather 
to integrate all the available data from multiple sources. 
For example, a hypotensive patient with a low cardiac 
output will present diﬀ erent diagnoses (hypovolemia, 
decreased contractility or obstruction) and hence require 
diﬀ erent treatments to a hypotensive patient with a high 
cardiac output (decreased vascular tone). Likewise, as 
discussed earlier, correct interpretation of a low cardiac 
output involves consideration of many factors (Figure 2), 
including some assessment of cardiac ﬁ lling (pressures or 
dimensions) to assess ventricular preload.
Principle 5: measurements of SvO2 can be helpful
SvO2 reﬂ ects the balance between oxygen consumption 
(VO2) and DO2 and thus provides an indication of the 
adequacy of tissue oxygenation. If there is no PAC in situ, 
the oxygen saturation in the superior vena cava (ScvO2) 
can be measured using a central venous catheter and has 
been proposed as a surrogate for SvO2. Importantly, 
ScvO2 represents just an approximation of the SvO2 [13] 
and the absolute values of ScvO2 and SvO2 are not 
interchangeable. Th e diﬀ erence between these two para-
meters is inﬂ uenced by the sampling site of central 
venous blood, the presence of left-to-right shunts, in-
complete mixing of venous blood, oxygen extraction in 
the renal and the splanchnic beds, redistribution of blood 
ﬂ ow through the upper and lower body, level of con-
scious ness (anesthesia) and myocardial VO2. Th e relia-
bility of ScvO2 is also dependent on the position of the tip 
of the catheter, with right atrial measurements closely 
Figure 1. Diagnostic algorithm based on use of 
echocardiography. CVP, central venous pressure; RV, right 
ventricular.
arterial catheter
central venous catheter
Fluid responsiveness ?
(low CVP ?)
present
hypovolemia likely
fluid challenge
echocardiography
small chambers
large ventricles
poor contractile state
valvulopathy
RV dilation
tamponade
(cardiogenic)
(obstructive)
Hemodynamic instability
absent
Figure 2. Factors infl uencing the interpretation of cardiac output 
(CO). EKG, electrocardiogram; NIRS, near-infrared spectral imaging; 
OPS, orthogonal polarization spectral imaging; PAOP, pulmonary 
artery occlusion pressure; PAP, pulmonary artery pressure; PgCO2, 
gastric intramucosal carbon dioxide partial pressure; RAP, right atrial 
pressure; SvO2, mixed venous oxygen saturation.
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approximating SvO2 and high vena cava measurements 
often deviating substantially from SvO2. In general, SvO2 
is more useful when the value is below normal (see 
below), even though in these conditions it may not reﬂ ect 
a hemodynamic problem. Simultaneous measurements 
of blood lactate levels can be helpful. A diagnostic 
algorithm based on SvO2 and cardiac output is shown in 
Figure 3.
Principle 6: a high cardiac output and a high SvO2 are not 
always best
Although ICU physicians may like to increase cardiac 
output and SvO2 by giving more ﬂ uid and inotropic 
agents, is this always good? Excessive ﬂ uid administration 
to increase cardiac output may result in ﬂ uid overload 
with massive edema formation and this may be associated 
with worse outcomes [14]; some systems measure 
extravascular lung water, which can help document this. 
Similarly, excessive doses of dobutamine can be detri-
mental, compromising myocardial function, especially in 
patients with coronary artery disease; giving inotropic 
agents in the presence of coronary artery disease is like 
trying to stimulate a tired horse. Using vasoactive agents 
and ﬂ uids to increase DO2 to supranormal levels in all 
patients may result in excessive mortality rates and this 
strategy has been abandoned [15]. A high ScvO2 has been 
suggested as a target for some high risk patients or in 
shock resuscitation, with Rivers and colleagues [16] 
reporting that septic patients assigned to an early goal-
directed therapy algorithm had higher ScvO2 values and 
reduced mortality rates. However, this was a strategy for 
early resuscitation of patients with severe sepsis in a 
single institution, and needs further validation in multi-
center studies, several of which are currently ongoing. 
Importantly, applying the same strategy in general ICU 
patients may not improve outcomes [17]. Indeed, in 
patients with sepsis, a high SvO2 may be the result of 
maldistribution of peripheral blood ﬂ ow and altered 
oxygen extraction, rather than adequate perfusion, such 
that patients may still deteriorate even with a high SvO2. 
In sepsis, a high cardiac output, like a high SvO2, can be 
associated with worse outcomes.
Principle 7: cardiac output is estimated, not measured
No bedside method is available to directly assess cardiac 
output, so all values obtained are estimates. As such, 
com parison of measurements obtained with diﬀ erent 
techniques results in relatively poor agreement and signi-
ﬁ  cant bias. Th e intermittent thermodilution technique is 
generally considered as the ‘reference’ standard, but has 
its own limitations. A measurement obtained by a less 
invasive technique may be preferable if it can be obtained 
more rapidly and easily, even if it is slightly less accurate. 
Importantly, the accuracy of absolute values may be less 
important if one is following trends, for example, to track 
the short-term eﬀ ects of therapies, such as ﬂ uid loading.
Principle 8: monitoring hemodynamic changes over short 
periods of time is important
Monitoring of acute changes in cardiac output can be 
important, for example, in patients at risk of acute 
bleeding or in assessing the response to ﬂ uid adminis-
tration to separate ﬂ uid responders from non-responders. 
Evaluating the response to a dobutamine or to a nitrate 
infusion is another example of this functional monitoring 
that may also have sound clinical applications. Th is 
assessment of hemodynamic variations observed during 
the challenge of the cardiovascular system has been 
termed ‘functional hemodynamic monitoring’ [18]. Th e 
study of slow changes in cardiac output over several days 
may be less relevant in most patients, although can be 
useful to follow the clinical course of the cardiac patient. 
Combining measures of multiple variables and their 
dynamic interactions in response to time and speciﬁ c 
treatments often increases the sensitivity and speciﬁ city of 
these monitoring modalities to identify speciﬁ c disease 
processes and quantify whether therapy is eﬀ ective or not.
Principle 9: continuous measurement of all hemodynamic 
variables is preferable
Although there are no data to demonstrate the 
superiority of continuous cardiac output measurements 
over intermittent monitoring, there has been a global 
evolution towards more continuous measurement of 
varia bles. We can now routinely measure various hemo-
dynamic variables continuously, including heart rate, 
arterial pressure and CVP. Using the thermodilution 
technique, one may not wish to go back to intermittent 
measurements of cardiac output by repeated injections of 
cold water boluses. It may even be preferable to have real-
time (beat-by-beat) continuous cardiac output measure-
ment rather than a built-in delay like the semi-continuous 
Figure 3. Diagnostic algorithm based on mixed venous oxygen 
saturation (SvO2) and cardiac output. VO2, oxygen consumption.
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HIGH                               LOW
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HIGH              LOW              HIGH               LOW
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cardiac output provided with the Vigilance™ system. 
Systems that are not continuous (for example, echo-
cardiography) or that require calibration (for example, 
trans pulmonary indicator dilution) may not provide the 
real-time data needed for optimal acute manage ment of 
unstable critically ill patients, whereas systems that 
provide continuous non-calibrated cardiac output measure-
ments suﬀ er from reduced accuracy.
Principle 10: non-invasiveness is not the only issue
Non-invasiveness is not the only goal. Although it is 
always preferable to be less invasive, being non-invasive 
is not always possible and may even be counter eﬀ ective. 
For example, continuous monitoring of arterial pressure 
is more invasive than intermittent monitoring but is 
helpful in hypotensive (or severe hypertensive) states. 
Likewise, a central venous catheter can be helpful to 
monitor the CVP and the ScvO2 (and also facilitates the 
rapid administration of ﬂ uids). Whenever possible, we 
should of course try to be as non-invasive as possible, but 
arterial pressure monitoring and CVP monitoring are 
still invasive. Echocardiography must be promoted more 
for its ability to oﬀ er a direct evaluation of cardiac 
function than for its non-invasiveness. Even though it is 
the most invasive method, the PAC is still of value in very 
sick patients with complex problems, for example, 
respiratory failure with shock and oliguria. At the other 
extreme, completely non-invasive bioimpedance has a 
place in healthy individuals, but little place in critically ill 
patients. Other monitoring systems are of use in patients 
with conditions somewhere between these two extremes. 
Th e optimal device depends on the type of patient, the 
question being asked, and the condition being managed 
or anticipated.
Conclusion
Th e ideal hemodynamic monitoring system should 
comprise all the key factors listed in Table 2; however, 
such a system does not currently exist so we must try and 
choose devices that have a maximum of these attributes, 
bearing in mind that there is no ‘one size ﬁ ts all’ type of 
system and one should, therefore, select the system most 
appropriate for each patient and, perhaps even more 
importantly, for each type of problem. It is important to 
be familiar with the technology being used, proﬁ ting 
from its advantages but recognizing its limitations. Most 
systems now oﬀ er (almost) continuous measurements, 
with the possible exception of echocardiography tech-
niques because it is diﬃ  cult to leave the probe in place 
for prolonged periods. Hemodynamic monitoring can be 
particularly helpful in the early stages of resusci tation, 
but is less useful when organ failure is established. Most 
importantly, one must never forget that it is not the 
monitoring itself that can improve outcomes but the 
changes in therapy guided by the data obtained.
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